On the other hand, Pérez Encinas et al.’ multicentric study concluded that CALR mutation type has prognostic value for the stratification of thrombotic risk in ET patients finding that CALR-type 2 mutation was a statistically significant protective factor for thrombosis [93]. This evidence concerns the gene CALR and essential thrombocythemia.